Skip to main content
رجوع
Watch Compare

Adagio Medical Holdings, Inc.

جودة البيانات: 100%
ADGM
Nasdaq Manufacturing Measuring & Analyzing Instruments
KWD 1.28
▼ KWD 0.13 (-9.22%)
القيمة السوقية: 31.32 M
السعر
KWD 1.41
القيمة السوقية
31.32 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Negative free cash flow of -19.39 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-682.19%
أقل من متوسط القطاع (-53.41%)
ROIC-65.46%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio0.84
Interest Coverage-7.53

التقييم

PE (TTM)
-1.25
أعلى من متوسط القطاع (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -1.3 -1.5
P/B — 1.6
ROE % -682.2 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -100.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -25.08 M
ROE -682.19% ROA -74.41%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -19.39 M
ROIC -65.46% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.84
Interest Coverage -7.53 Asset Turnover 0.00
Working Capital -1.56 M Tangible Book Value -22.25 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.25 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -61.91%
Market Cap 31.32 M Enterprise Value 47.83 M
Per Share
EPS (Diluted TTM) -1.51 Revenue / Share 0.00
FCF / Share -0.87 OCF / Share -0.86
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 77.29%
SBC-Adj. FCF -19.98 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 0.0 269,000.0
Net Income -25.08 M -53.76 M
EPS (Diluted) -1.51 -3.70
Gross Profit — —
Operating Income -21.89 M -62.48 M
EBITDA — —
R&D Expenses 10.64 M 4.63 M
SG&A Expenses 10.57 M 6.98 M
D&A 970,000.0 740,000.0
Interest Expense 2.91 M 1.11 M
Income Tax 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 43.25 M 48.45 M
Total Liabilities 30.85 M 28.54 M
Shareholders' Equity 12.40 M 19.91 M
Total Debt 21.04 M 16.08 M
Cash & Equivalents 17.11 M 20.59 M
Current Assets 20.08 M 25.35 M
Current Liabilities 8.23 M 7.76 M